A pivotal, phase III trial of AC-1204 in patients with Alzheimer's disease.

Trial Profile

A pivotal, phase III trial of AC-1204 in patients with Alzheimer's disease.

Planning
Phase of Trial: Phase III

Latest Information Update: 20 May 2016

At a glance

  • Drugs AC 1204 (Primary)
  • Indications Alzheimer's disease
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 20 May 2016 New trial record
    • 01 May 2016 According to an Accera media release, this trial will be required for regulatory approval of the drug which company plans to initiate early next year. Data from NOURISH AD will inform the design of this study.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top